Terms And Conditions
  1. Home
  2. Terms And Conditions
PharmAust Limited: Clinical Trial Delivers Pr...
By ACE Investors / 25 Sep 2020
Read More
Immutep Limited: Worldwide Leader in Developi...
By ACE Investors / 24 Sep 2020
Read More
Paradigm Biopharmaceuticals Limited: Well Fun...
By ACE Investors / 22 Sep 2020
Read More
Resmed Inc: Focus on Increasing SaaS Business...
By ACE Investors / 21 Sep 2020
Read More
Orthocell Limited: Well Established to Progre...
By ACE Investors / 11 Sep 2020
Read More
Volpara Health Technologies Limited: Continue...
By ACE Investors / 10 Sep 2020
Read More
Medical Developments International Limited: S...
By ACE Investors / 09 Sep 2020
Read More
Kazia Therapeutics Limited – Management Inc...
By ACE Investors / 07 Sep 2020
Read More
Cynata Therapeutics Limited – Significant C...
By ACE Investors / 07 Sep 2020
Read More
Pharmaxis Limited – Strong Small Cap Drug D...
By ACE Investors / 04 Sep 2020
Read More
MGC Pharmaceuticals Limited – Leading the W...
By ACE Investors / 31 Aug 2020
Read More
Osteopore Limited: Why This Nascent Medical D...
By ACE Investors / 28 Aug 2020
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors